CoreFirst Bank & Trust bought a new stake in The Clorox Company (NYSE:CLX – Free Report) during the fourth quarter, Holdings Channel.com reports. The institutional investor bought 645 shares of the company’s stock, valued at approximately $105,000.
Several other hedge funds also recently bought and sold shares of CLX. Brooklyn Investment Group grew its stake in shares of Clorox by 163.8% in the fourth quarter. Brooklyn Investment Group now owns 153 shares of the company’s stock valued at $25,000 after buying an additional 95 shares in the last quarter. Continuum Advisory LLC increased its stake in Clorox by 300.0% during the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after purchasing an additional 138 shares during the period. Millstone Evans Group LLC purchased a new stake in Clorox during the fourth quarter worth about $31,000. Asset Planning Inc acquired a new stake in shares of Clorox during the fourth quarter worth about $32,000. Finally, Halbert Hargrove Global Advisors LLC purchased a new position in shares of Clorox in the fourth quarter valued at approximately $36,000. Hedge funds and other institutional investors own 78.53% of the company’s stock.
Wall Street Analyst Weigh In
A number of research firms have issued reports on CLX. Barclays increased their target price on shares of Clorox from $130.00 to $140.00 and gave the stock an “underweight” rating in a report on Wednesday, February 5th. StockNews.com cut Clorox from a “buy” rating to a “hold” rating in a research note on Sunday, January 5th. JPMorgan Chase & Co. boosted their target price on Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a research note on Tuesday, February 4th. Evercore ISI increased their price target on Clorox from $145.00 to $155.00 in a research report on Tuesday, February 4th. Finally, DA Davidson lowered their price objective on Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a research report on Wednesday, February 5th. Three equities research analysts have rated the stock with a sell rating, eleven have assigned a hold rating and one has given a buy rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and an average target price of $159.62.
Clorox Stock Performance
Shares of CLX opened at $141.80 on Wednesday. The company has a market capitalization of $17.47 billion, a price-to-earnings ratio of 38.74, a price-to-earnings-growth ratio of 2.62 and a beta of 0.45. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The stock has a 50 day moving average price of $152.23 and a 200 day moving average price of $159.43.
Clorox (NYSE:CLX – Get Free Report) last posted its earnings results on Monday, February 3rd. The company reported $1.55 EPS for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a net margin of 6.38% and a return on equity of 316.87%. During the same period in the prior year, the business posted $2.16 EPS. Research analysts predict that The Clorox Company will post 7.15 EPS for the current fiscal year.
Clorox Announces Dividend
The company also recently announced a quarterly dividend, which will be paid on Friday, May 9th. Stockholders of record on Wednesday, April 23rd will be issued a $1.22 dividend. This represents a $4.88 annualized dividend and a dividend yield of 3.44%. The ex-dividend date of this dividend is Wednesday, April 23rd. Clorox’s payout ratio is currently 133.33%.
Clorox Company Profile
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
Featured Stories
- Five stocks we like better than Clorox
- There Are Different Types of Stock To Invest In
- Innovation Incubators: Survey of Entrepreneurs Reveals The Cities Most Supportive of Startups
- Best ESG Stocks: 11 Best Stocks for ESG Investing
- NVIDIA Insiders Sell: This Is What It Means for the MarketĀ
- Do ETFs Pay Dividends? What You Need to Know
- Space Stocks Bottoming: Which Are Positioned Best for a Bounce?
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.